Literature DB >> 23485198

Intestinal mucosal MMP-1 - a prognostic factor in colon cancer.

Marcus Langenskiöld1, Marie-Lois Ivarsson, Lena Holmdahl, Peter Falk, Christina Kåbjörn-Gustafsson, Eva Angenete.   

Abstract

OBJECTIVE: There is evidence that transforming growth factor-β₁ (TGF-β₁) and matrix metalloproteinases (MMPs) play an important role in tumor invasion and progression in colorectal cancer. The aim of this study was to assess their utility in prediction of cancer-specific survival (CSS).
MATERIALS AND METHODS: 136 patients undergoing curative surgery for colorectal carcinoma were prospectively included. Samples were taken from tumor and tumor-free intestinal mucosa and ELISA was used to assess protein levels in the tissues. Patients were followed for CSS. The median follow-up time for all included patients was 65 months (range: 45-92). The main outcome measure was CSS.
RESULTS: T stage, lymph node involvement and high levels of MMP-1 as well as MMP-9 in tumor-free mucosa tissue were significantly associated with CSS in colon cancer in univariate analysis. This prognostic strength was maintained for MMP-1 and N-status in multivariate analysis.
CONCLUSIONS: The results indicate that MMP-1 is independently associated with CSS in patients with colon cancer. Furthermore, a possible clinical implication is that MMP-1 protein expression in tumor-free mucosa could identify colon cancer patients with poor CSS in need of more intensified adjuvant treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23485198     DOI: 10.3109/00365521.2012.708939

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  18 in total

1.  Gene expression profiling to identify the toxicities and potentially relevant disease outcomes due to endosulfan exposure.

Authors:  Dan Xu; Shuai Li; Limei Lin; Fei Qi; Xiaoming Hang; Yeqing Sun
Journal:  Toxicol Res (Camb)       Date:  2016-01-22       Impact factor: 3.524

Review 2.  Targeting M3 Muscarinic Receptors for Colon Cancer Therapy.

Authors:  Jessica Felton; Shien Hu; Jean-Pierre Raufman
Journal:  Curr Mol Pharmacol       Date:  2018       Impact factor: 3.339

3.  The matrix metalloproteinase-7 and pro-enzyme of metalloproteinase-1 as a potential marker for patients with rectal cancer without distant metastasis.

Authors:  Malgorzata Fuksiewicz; Beata Kotowicz; Andrzej Rutkowski; Maria Kowalska
Journal:  Tumour Biol       Date:  2014-12-31

4.  Interstitial collagenase MMP-1 and EMMPRIN in cell lines and in clinical specimens of cervical squamous cell carcinoma.

Authors:  Nina I Solovyeva; Olga S Timoshenko; Elena V Kugaevskaya; Tatyana A Gureeva
Journal:  Mol Biol Rep       Date:  2021-09-08       Impact factor: 2.316

Review 5.  Impact of proteolytic enzymes in colorectal cancer development and progression.

Authors:  László Herszényi; Loránd Barabás; István Hritz; Gábor István; Zsolt Tulassay
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

6.  Curcumin suppresses crosstalk between colon cancer stem cells and stromal fibroblasts in the tumor microenvironment: potential role of EMT.

Authors:  Constanze Buhrmann; Patricia Kraehe; Cora Lueders; Parviz Shayan; Ajay Goel; Mehdi Shakibaei
Journal:  PLoS One       Date:  2014-09-19       Impact factor: 3.240

7.  Effect of Cnidii Rhizoma on nitric oxide production and invasion of human colorectal adenocarcinoma HT-29 cells.

Authors:  Kyung-Soo Nam; Byung Geun Ha; Yun-Hee Shon
Journal:  Oncol Lett       Date:  2014-11-03       Impact factor: 2.967

8.  Stability of matrix metalloproteinase-9 as biological marker in colorectal cancer.

Authors:  Andreas Jonsson; Claes Hjalmarsson; Peter Falk; Marie-Lois Ivarsson
Journal:  Med Oncol       Date:  2018-03-09       Impact factor: 3.064

9.  Prognostic value of transforming growth factor-beta in patients with colorectal cancer who undergo surgery: a meta-analysis.

Authors:  Xin-Lin Chen; Zhuo-Qun Chen; Shui-Lian Zhu; Tian-Wen Liu; Yi Wen; Yi-Sheng Su; Xu-Jie Xi; Yue Hu; Lei Lian; Feng-Bin Liu
Journal:  BMC Cancer       Date:  2017-04-04       Impact factor: 4.430

10.  Combined upregulation of matrix metalloproteinase-1 and proteinase-activated receptor-1 predicts unfavorable prognosis in human nasopharyngeal carcinoma.

Authors:  Rui Yang; Yu Xu; Peizhong Li; Xin Zhang; Junying Wang; Dongsheng Gu; Yao Wang
Journal:  Onco Targets Ther       Date:  2013-08-20       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.